Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloé Guillas

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Vaccine|January 23, 2020
Subcutaneous vaccination with a live attenuated Yersinia pseudotuberculosis plague vaccineAnne Derbise, Chloé Guillas, Christiane Gerke, et al.
Vaccine|November 24, 2018
Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccineChristian E Demeure, Anne Derbise, Chloé Guillas, et al.
Vaccine|February 20, 2025
Contribution of the type 3 secretion system to adaptive and innate immunity induced by a live Yersinia pseudotuberculosis plague vaccineAnne Derbise, Chloé Guillas, Hebert Echenique-Rivera, et al.
The Journal of Infectious Diseases|September 22, 2017
Enhanced Macrophage M1 Polarization and Resistance to Apoptosis Enable Resistance to PlagueEmilia Pachulec, Rym Ben Abdelwahed Bagga, Lucie Chevallier, et al.
Oncotarget|October 27, 2017
Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial functionLucie Hebert, Dorine Bellanger, Chloé Guillas, et al.
Frontiers in Cardiovascular Medicine|July 24, 2023
Therapeutic potential of extracellular vesicles derived from cardiac progenitor cells in rodent models of chemotherapy-induced cardiomyopathyManon Desgres, Bruna Lima Correa, Lorena Petrusca, et al.
Theranostics|November 24, 2021
Extracellular vesicles fail to trigger the generation of new cardiomyocytes in chronically infarcted heartsBruna Lima Correa, Nadia El Harane, Manon Desgres, et al.
Cardiovascular Research|February 13, 2020
Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted heartsBruna Lima Correa, Nadia El Harane, Ingrid Gomez, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Vaccine|January 23, 2020
Subcutaneous vaccination with a live attenuated Yersinia pseudotuberculosis plague vaccineAnne Derbise, Chloé Guillas, Christiane Gerke, et al.
Vaccine|November 24, 2018
Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccineChristian E Demeure, Anne Derbise, Chloé Guillas, et al.
Vaccine|February 20, 2025
Contribution of the type 3 secretion system to adaptive and innate immunity induced by a live Yersinia pseudotuberculosis plague vaccineAnne Derbise, Chloé Guillas, Hebert Echenique-Rivera, et al.
The Journal of Infectious Diseases|September 22, 2017
Enhanced Macrophage M1 Polarization and Resistance to Apoptosis Enable Resistance to PlagueEmilia Pachulec, Rym Ben Abdelwahed Bagga, Lucie Chevallier, et al.
Oncotarget|October 27, 2017
Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial functionLucie Hebert, Dorine Bellanger, Chloé Guillas, et al.
Frontiers in Cardiovascular Medicine|July 24, 2023
Therapeutic potential of extracellular vesicles derived from cardiac progenitor cells in rodent models of chemotherapy-induced cardiomyopathyManon Desgres, Bruna Lima Correa, Lorena Petrusca, et al.
Theranostics|November 24, 2021
Extracellular vesicles fail to trigger the generation of new cardiomyocytes in chronically infarcted heartsBruna Lima Correa, Nadia El Harane, Manon Desgres, et al.
Cardiovascular Research|February 13, 2020
Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted heartsBruna Lima Correa, Nadia El Harane, Ingrid Gomez, et al.
Pageof 1